Statins drugs prescribed to treat high cholesterol may also work to slow prostate growth in men who have elevated PSA levels, according to a new analysis.

A collaborative expedition into the deep genetics of prostate cancer has uncovered a distinct subtype of the disease, one that appears to account for up to 15 percent of all cases, say researchers.

Researchers have demonstrated that a hormone-depleting drug approved for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, according to a new clinical study.

In the United States, where blacks bear a disproportionate burden of the HIV/AIDS epidemic, black religious institutions could help turn the tide. In a new study based on dozens of interviews and focus groups with 38 of Philadelphia's most influential black religious leaders, physicians and public health researchers find that traditional barriers to preaching about HIV prevention could give way to faith-friendly messages about getting tested and staying on treatment.

A new study suggests that men undergoing robotic-assisted surgery for prostate cancer should look for a doctor who has performed at least 1,000 surgeries and who actively seeks to improve and enhance his surgical skills to help ensure a successful post-surgery recovery of erectile function.

Researchers found that administering a common chemotherapy drug before bone tumors took root actually fertilized the bone marrow, enabling cancer cells, once introduced, to seed and grow more easily.

Nice guys do finish last at least when it comes to procreation, according to a new study that answers the question of why women choose bad boys. New research has demonstrated that hormones associated with ovulation influence women's perceptions of men as potential fathers.

A new study adds to the evidence that certain non-oral hormonal contraceptives carry a higher risk of serious blood clots than others.

A study conducted in Chile has found that the most important factor in reducing maternal mortality is the educational level of women.

Researchers are hoping to better understand why the mutated genes for breast and ovarian cancer are not passed on more frequently from one generation of women to the next.